Lidocaína Pls

Lidocaine, the active ingredient in Lidocaína Pls, is a local anesthetic presented as a topical preparation for skin and mucous membrane use. It provides reversible nerve‑impulse blockade to relieve pain during minor superficial procedures and diagnostic examinations.

GNH USA supplies Lidocaína Pls as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide, with a focus on EU‑regulated markets and adherence to quality standards.

Lidocaine is used to achieve temporary loss of sensation in superficial tissues and mucous membranes.

- Local anesthesia of skin: provides temporary numbness for minor skin procedures such as biopsies or suturing. - Local anesthesia of mucous membranes: numbs oral, nasal or genital mucosa for diagnostic or therapeutic interventions. - Pain relief for minor superficial procedures: reduces discomfort during laser therapy, dermabrasion or minor surgical excisions.

Topical lidocaine is generally well tolerated, but local and systemic reactions can occur.

Common Side Effects: - Mild skin irritation or erythema at the application site. - Transient itching or burning sensation. - Localized numbness persisting longer than the procedure. - Allergic contact dermatitis. - Dryness or peeling of the skin.

Serious or Rare Side Effects: - Systemic toxicity presenting as dizziness, seizures or cardiovascular depression. - Severe allergic reaction (anaphylaxis). - Methemoglobinemia, especially with extensive application. - Tissue necrosis if applied to broken skin in large amounts.

When using Lidocaína Pls, consider the following safety measures.

- Allergy assessment: confirm no known hypersensitivity to lidocaine or amide‑type anesthetics. - Application area: limit to intact skin or mucosa and avoid large surface coverage. - Quantity control: do not exceed the recommended amount for the specific procedure. - Avoid ocular exposure: keep the product away from eyes and mucosal surfaces not intended for treatment. - Monitor for systemic signs: watch for dizziness, tinnitus, or altered mental status. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lidocaine may interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide) – may increase cardiac toxicity. - Concurrent use of other local anesthetics – risk of cumulative systemic exposure.

Moderate Interactions (Monitor Closely): - Beta‑blockers – may potentiate bradycardia when systemic absorption occurs. - Epinephrine‑containing products – can increase local vasoconstriction and raise plasma lidocaine levels. - Monoamine oxidase inhibitors (MAOIs) – may enhance central nervous system effects.